Drug Type CpG ODN |
Synonyms- |
Target |
Action agonists |
Mechanism TLR9 agonists(Toll like receptor 9 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Solid tumor | Preclinical | United States | - | |
| Bladder Cancer | Discovery | United States | - | |
| Colonic Cancer | Discovery | United States | - | |
| Diffuse Large B-Cell Lymphoma | Discovery | United States | - | |
| Follicular Lymphoma | Discovery | United States | - | |
| Head and Neck Neoplasms | Discovery | United States | - | |
| Leukemia | Discovery | United States | - | |
| Mantle-Cell Lymphoma | Discovery | United States | - | |
| Marginal Zone B-Cell Lymphoma | Discovery | United States | - | |
| Melanoma | Discovery | United States | - |





